Anticancer agents Flashcards

1
Q

function of KRAS

A

transmits external growth signals to the nucleus
drives cell growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is KRAS activated/inactivated

A

activated - binding to GTP
inactivated - when the bound GTP is hydrolysed to GDP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the function of Glivec (imitanib)

A

holds the activation loop in an inactive state , preventing dimerisation
preventing cell survival
acts as a tyrosine kinase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how do cancer cells resist glivec

A

mutant in the ABL locus
threonine to isoleucine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what percentage of patients will need alternative treatment due to imitanib therapy

A

20-40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what drug overcomes imitanib resistance and how

A

Dasatinib, sprycel
binds to active form of ABL
overcomes 14 of the 15 imitanib mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what percentage of patients unresponsive to imitanib responded to nilotinib

A

92%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what mutation can nilotinib (a second generation) not target

A

T315I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is a third generation bcr-abl inhibitor

A

SGX393

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what would be the point of combination therapy of nilotinib/dasatinib (second generation with) with SGX393

A

to pre-empt any bcr-abl inhibitor resistant mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the most common mutation cancer cells employ to resistant EGRF inhibiting antibodies

A

T790M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how do second generations EGFR TKI’s perform their function

A

form irreversible covalent bonds with the ATP-binding site of EGFR as well as other HER family of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what mutation can only 3rd generation EGFR TKI’s target

A

T790M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how does vemurafenib inhibit cutaneous melanomas

A

40-60% of cutaneous melanomas are positive for a BRAF mutation - BRAF V600E compromise 90% of those mutations
vemurafenib blocks BRAF V600E
blocking the survival signals to the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the different ways cancer cells can reestablish their survival signals

A

increase in COT - to activate MEK
direct MEK1/2 mutations - to activate ERK
other BRAF V600E mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what do tumour cells express to prevent an immune response

A

PD-1 receptors

17
Q

what is the outcome of using anti-PD-1 antibodies

A

T-cells able to elicit anti-tumour response

18
Q

function of Bevacizumab (avastin)

A

targets vascular endothelial growth factor (VEGF)
creates hypoxic conditions surrounding the tumour

19
Q

what does chemotherapy target

A

targets all fast-growing cells

20
Q

what is the function of alkylating agents as a chemotherapeutic

A

cross-links two DNA strands to prevent DNA replication

21
Q

function of cisplatin

A

also cross-links DNA

22
Q

function of antimetabolites as chemotherapeutics

A

produce analogous that compete with DNA synthesis
methotrexate - folic acid analogue
5-FU - thymine analogue
cytarabine - pyrimidine analogue

23
Q

function of plant alkaloids and their mechanism of action

A

they are mitotic inhibitors
bind to tubulin - interferes with spindle assembly in mitosis

24
Q

what is the function of the second class of plant alkaloids

A

topoisomerase inhibitors - inhibits the unwinding of supercoiled DNA

25
Q

what is the function of antibiotics in terms of chemotherapy

A

binds non-covalently to DNA
cell cycle stage - non-specific

26
Q
A